NASDAQ:CMTA - Clementia Pharmaceuticals SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$26.35 0.00 (0.00 %)
(As of 04/17/2019)
Previous Close$26.35
Today's Range$26.28 - $26.69
52-Week Range$8.10 - $26.73
Volume716,706 shs
Average Volume145,059 shs
Market Capitalization$1.00 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.64

SEC Filings

Clementia Pharmaceuticals (NASDAQ:CMTA) SEC Filings

DateFilerForm TypeView
04/29/2019
7:27 AM
Clementia Pharmaceuticals (Filer)
Form 15-12B
View Filing
04/18/2019
11:15 PM
Clementia Pharmaceuticals (Filer)
Form EFFECT
View Filing
04/18/2019
8:10 AM
Clementia Pharmaceuticals (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
View Filing
04/18/2019
7:04 AM
Clementia Pharmaceuticals (Filer)
Form S-8 POS
View Filing
04/18/2019
7:03 AM
Clementia Pharmaceuticals (Filer)
Form POS AM
View Filing
04/18/2019
7:01 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/11/2019
11:00 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/09/2019
11:39 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/13/2019
8:00 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/13/2019
6:23 AM
Clementia Pharmaceuticals (Subject)
New Enterprise Associates 15, L.P. (Filed by)
Form SC 13D
View Filing
03/06/2019
3:48 PM
Clementia Pharmaceuticals (Subject)
Ipsen, S.A. (Filed by)
Form SC 13D
View Filing
03/06/2019
3:35 PM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/28/2019
10:53 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/26/2019
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/25/2019
3:23 PM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/25/2019
7:10 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/20/2019
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/13/2019
3:29 PM
BAKER BROS. ADVISORS LP (Filed by)
Clementia Pharmaceuticals (Subject)
Form SC 13G
View Filing
02/13/2019
8:22 AM
Clementia Pharmaceuticals (Subject)
New Enterprise Associates 15, L.P. (Filed by)
Form SC 13G/A
View Filing
02/12/2019
2:15 PM
Clementia Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G
View Filing
02/12/2019
8:31 AM
Clementia Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
View Filing
02/11/2019
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/30/2018
8:00 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/21/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/07/2018
5:32 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/07/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/05/2018
2:49 PM
Clementia Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
View Filing
10/30/2018
3:02 PM
Clementia Pharmaceuticals (Filer)
Form 424B5
View Filing
10/30/2018
5:29 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/29/2018
3:12 PM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/29/2018
3:07 PM
Clementia Pharmaceuticals (Filer)
Form 424B5
View Filing
10/23/2018
3:03 PM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/22/2018
5:05 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/22/2018
5:04 AM
Clementia Pharmaceuticals (Filer)
Form 424B5
View Filing
10/18/2018
11:15 PM
Clementia Pharmaceuticals (Filer)
Form EFFECT
View Filing
10/05/2018
4:10 PM
Clementia Pharmaceuticals (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
View Filing
10/02/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/26/2018
7:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/05/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/16/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/09/2018
5:31 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/09/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
07/13/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
07/05/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/31/2018
8:00 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/31/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/23/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/09/2018
6:45 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/09/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/02/2018
9:01 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/02/2018
9:00 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/02/2018
9:00 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/20/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/23/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/06/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/28/2018
3:05 PM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/28/2018
3:01 PM
Clementia Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
View Filing
02/08/2018
10:10 AM
Clementia Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
View Filing
02/07/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/31/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/29/2018
2:45 PM
Clementia Pharmaceuticals (Subject)
New Enterprise Associates 15, L.P. (Filed by)
Form SC 13G
View Filing
01/26/2018
11:05 AM
Clementia Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
View Filing
01/25/2018
8:19 PM
Clementia Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
View Filing
01/03/2018
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/12/2017
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/05/2017
5:30 AM
Clementia Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
This page was last updated on 5/20/2019 by MarketBeat.com Staff

Featured Article: What is Green Investing?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel